Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2020-04-14 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
2019年度公司内部控制自我评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an internal control self-assessment report for the year 2019 by 华邦生命健康股份有限公司. It discusses the company's internal control evaluation, including financial and non-financial control defect standards, control environment, risk assessment, control activities, and audit control. The document is comprehensive, contains detailed explanations of internal control processes, evaluation criteria, and conclusions about the effectiveness of internal controls as of December 31, 2019. It is not a general annual report or earnings release but a specialized report focused on internal control evaluation. This matches the description of an Audit Report / Information (AR), which includes audit reports and applied accounting principles and internal control evaluations. The document is not an announcement or a brief summary but a full report with substantive content. Therefore, the appropriate classification is AR with high confidence. FY 2019
2020-04-14 Chinese
关于申请发行中期票据的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Huabang Life Health Co., Ltd. regarding the application for issuance of medium-term notes (中期票据). It details the board meeting resolution, issuance plan, authorization matters, and independent directors' opinions. The document is relatively short (1833 characters) and focuses on the company's financing activity, specifically the issuance of debt instruments. There are no financial statements or detailed financial performance data included. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a regulatory filing or report publication announcement. Therefore, the correct classification is CAP with high confidence.
2020-04-14 Chinese
独立董事关于第七届董事会第十四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion report related to various corporate governance and financial matters of Huabang Life Health Co., Ltd. It covers topics such as related party transactions, external guarantees, internal control self-assessment, profit distribution proposals, appointment of auditors, use of raised funds, retrospective financial data adjustments, guarantees and financial assistance to a subsidiary hospital, cash management of idle raised funds, and issuance of medium-term notes and overseas bonds. The document references compliance with laws, regulations, and company articles, and provides independent opinions on these matters. It is not a full annual or interim financial report, nor a simple announcement or certification. It is a detailed governance-related report expressing independent directors' opinions on board meeting matters and company governance issues. Therefore, it fits best under Board/Management Information (MANG). The document length is 4222 characters, which is relatively short but contains substantive governance content rather than just an announcement or certification. Hence, the classification is MANG with high confidence.
2020-04-14 Chinese
关于举行2019年年度报告业绩网上说明会的公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (565 characters) about holding an online performance explanation meeting for the 2019 Annual Report. It states the date and time of the meeting and provides links to where the full 2019 Annual Report and its summary have been published. The document does not contain the actual annual report or financial data but rather announces the event related to the report. According to the 'Menu vs Meal' rule, this is a report publication announcement, not the report itself.
2020-04-14 Chinese
关于召开2019年年度股东大会的通知公告
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2019 Annual General Meeting (AGM) of Huabang Life Health Co., Ltd. It includes information about the meeting date, voting procedures, agenda items to be discussed, and instructions for shareholders to participate either in person or via online voting. The document does not contain financial statements or results but rather the announcement and procedural details for the AGM. It also lists the agenda items to be voted on, including reports and proposals, but does not provide the voting results or the reports themselves. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself.
2020-04-14 Chinese
2019年年度审计报告
Regulatory Filings
2020-04-14 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.